Hjem › Monoklonal gammopati av usikker betydning › New York
Kliniske studier for Monoklonal gammopati av usikker betydning i New York
3 studier for Monoklonal gammopati av usikker betydning søker deltakere på steder i New York.
Byer i New York
Offisiell studietekst (engelsk)
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- og 1 flere
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06055894A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
- NYU Langone Health Perlmutter Cancer Center, New York
- Stony Brook University Hospital, Stony Brook
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 8. jul. 2026 · NCT06140524A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
- Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- og 1 flere
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 16. apr. 2026 · NCT05640843Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.